Table: Peptidream -9-MTH parent results
May 10 (Reuters)-
Peptidream Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Mar 31, 2016 Mar 31, 2015 Jun 30, 2016
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 2.68 535 mln 3.10
(+400.7 pct) (-10.3 pct) (+25.2 pct)
Operating 1.54 loss 72 mln 1.31
(-154.8 pct) (-5.9 pct)
Recurring 1.46 12 mln 1.27
(-92.4 pct) (-15.3 pct)
Net 977 mln 5 mln 835 mln
(-95.0 pct) (-16.8 pct)
EPS 17.65 yen 0.10 yen 15.13 yen
EPS Diluted 15.18 yen 0.08 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Peptidream Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4587.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on PeptiDream
See all newsTable: Peptidream 6-MTH group results (IFRS)
Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
Brief: PeptiDream Announces First Dosing Of 64cu-Pd-29,875 In Gastric Cancer Patients
Table: Peptidream -Q1 group results (IFRS)
Brief: Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner